![Philip T. Sager](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philip T. Sager
Chief Tech/Sci/R&D Officer at Thryv Therapeutics, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Paul Truex | M | 55 |
Thryv Therapeutics, Inc.
![]() Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada. | 20 years |
Debra A. Odink | M | 60 |
Thryv Therapeutics, Inc.
![]() Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada. | 15 years |
Marc Vidal | M | - |
Thryv Therapeutics, Inc.
![]() Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada. | 5 years |
Saumya Das | M | - |
Thryv Therapeutics, Inc.
![]() Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada. | 9 years |
Robert Booth | M | 70 |
Thryv Therapeutics, Inc.
![]() Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada. | - |
Jean-François Pariseau | M | 54 |
Thryv Therapeutics, Inc.
![]() Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada. | 3 years |
Linda Higgins | M | 62 | 14 years | |
Melissa Koomey | F | - |
Thryv Therapeutics, Inc.
![]() Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada. | 2 years |
Shi Yin Foo | M | - |
Thryv Therapeutics, Inc.
![]() Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada. | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Thompson | M | 57 | 2 years | |
Christopher Henney | M | 83 | 11 years | |
May Liu | F | 48 | 11 years | |
Brent Furse | M | 55 | - | |
Thomas Paul Koestler | M | 72 |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | - |
Dan Spiegelman | M | 65 | 4 years | |
Steven Engle | M | 69 | 3 years | |
Sanford Zweifach | M | 68 | 3 years | |
Colin Hislop | M | 66 | 11 years | |
Kevin Lofton | M | 69 | 15 years | |
Brian Mueller | M | 50 | 6 years | |
Robert Janssen | M | 70 | 2 years | |
Jung Choi | F | 54 | 8 years | |
Charles Olson | M | 66 | 7 years | |
Nikhil Agarwal | M | - | 3 years | |
Kenneth F. Boehm | M | - | 11 years | |
Temi Oduozor | F | 46 | 3 years | |
Erik Emerson | M | 53 | 3 years | |
Matthew Lang | M | 47 | 8 years | |
Holly Kramen | F | - | 1 years | |
Nicole White | F | 44 | 6 years | |
Elvia Cowan | F | 51 | 3 years | |
Elizabeth Ann Fagan | M | 74 | 2 years | |
Arvinder Dhalla | M | - | 6 years | |
Renee Martin | M | - | 8 years | |
Carol Brosgart | M | 72 | 11 years | |
James F. McLeod | M | - |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | - |
Stephen M. Chang | M | 68 |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | 6 years |
Larry Wang | M | - |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | 6 years |
Steven Pfeiffer | M | 48 | 4 years | |
Su Han Tang | M | 59 |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | 7 years |
Sara Zaknoen | M | 65 |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | 4 years |
Tracy Lawhon | F | - |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | 7 years |
Melissa Yeager | F | - | 8 years | |
Alexander R. Giaquinto | M | 80 |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | 10 years |
David Mazzo | M | 67 |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | 4 years |
Klara Dickinson-Eason | F | 57 | 2 years | |
Cecil B. Pickett | M | 78 |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | 4 years |
William R. Shanahan | M | 74 | 2 years | |
Patrick M. Murphy | M | 67 | - | |
Louis Lange | M | 72 | - | |
Pawel Trawkowski | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 45 | 88.24% |
Canada | 8 | 15.69% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Philip T. Sager
- Personal Network